[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease
DP Tashkin, R Elashoff, PJ Clements… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
Cyclophosphamide versus placebo in scleroderma lung disease
DP Tashkin, R Elashoff, PJ Clements, J Goldin… - 2006 - pubmed.ncbi.nlm.nih.gov
Background We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
Cyclophosphamide versus placebo in scleroderma lung disease.
DP Tashkin, R Elashoff, PJ Clements… - The New England …, 2006 - europepmc.org
Background We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
[PDF][PDF] Cyclophosphamide versus Placebo in Scleroderma Lung Disease
DP Tashkin, R Elashoff, PJ Clements, J Goldin… - N Engl J …, 2006 - researchgate.net
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
Cyclophosphamide versus placebo in scleroderma lung disease
DP Tashkin, R Elashoff, PJ Clements… - … England Journal of …, 2006 - pure.johnshopkins.edu
BACKGROUND: We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
Cyclophosphamide versus placebo in scleroderma lung disease
DP Tashkin, R Elashoff… - New England …, 2006 - scholars.northwestern.edu
BACKGROUND: We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
[PDF][PDF] Cyclophosphamide versus Placebo in Scleroderma Lung Disease
DP Tashkin, R Elashoff, PJ Clements, J Goldin… - N Engl J Med, 2006 - academia.edu
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
[引用][C] Cyclophosphamide versus placebo in seleroderma lung disease
T DP - N Engl J Med, 2006 - cir.nii.ac.jp
[PDF][PDF] Cyclophosphamide versus Placebo in Scleroderma Lung Disease
DP Tashkin, R Elashoff, PJ Clements, J Goldin… - N Engl J Med, 2006 - Citeseer
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to
determine the effects of oral cyclophosphamide on lung function and health-related …
determine the effects of oral cyclophosphamide on lung function and health-related …
[引用][C] Cyclophosphamide versus placebo in scleroderma lung disease
DP TASHKIN, R ELASHOFF… - The New England …, 2006 - pascal-francis.inist.fr
Cyclophosphamide versus placebo in scleroderma lung disease CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …